Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications.
作者信息
Soiza Roy L, Boustani Malaz A, Campbell Noll L, Mangoni Arduino A
机构信息
NHS Grampian and Ageing Clinical and Experimental Group, University of Aberdeen, Aberdeen, United Kingdom.
Regenstrief Institute, University of Indiana, Bloomington, IN, United States.
出版信息
Front Pharmacol. 2021 Dec 15;12:820051. doi: 10.3389/fphar.2021.820051. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Deprescribing and Minimizing Use of Anticholinergic Medications.
Front Pharmacol. 2021 Dec 15;12:820051. doi: 10.3389/fphar.2021.820051. eCollection 2021.
2
Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
Ann Pharmacother. 2016 Aug;50(8):625-36. doi: 10.1177/1060028016652997. Epub 2016 Jun 1.
3
Minimizing anticholinergic drug prescribing in older hospitalized patients: a full audit cycle.
Ther Adv Drug Saf. 2014 Jun;5(3):121-8. doi: 10.1177/2042098614523638.
4
Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity.
Int J Clin Pharm. 2018 Oct;40(5):991-996. doi: 10.1007/s11096-018-0673-1. Epub 2018 Jun 20.
5
A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Expert Opin Drug Saf. 2018 Jan;17(1):39-49. doi: 10.1080/14740338.2018.1397625. Epub 2017 Nov 6.
6
Anticholinergics: theoretical and clinical overview.
Expert Opin Drug Saf. 2016 Jun;15(6):753-68. doi: 10.1517/14740338.2016.1165664. Epub 2016 Mar 30.
7
Deprescribing medications in older people: a narrative review.
Drugs Today (Barc). 2018 Aug;54(8):489-498. doi: 10.1358/dot.2018.54.8.2856495.
8
Deprescribing anticholinergic and sedative medicines: protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities.
BMJ Open. 2017 Apr 16;7(4):e013800. doi: 10.1136/bmjopen-2016-013800.
9
Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study.
Br J Gen Pract. 2016 Aug;66(649):e552-60. doi: 10.3399/bjgp16X685669. Epub 2016 Jun 6.
10
Deprescribing of Medicines in Care Homes-A Five-Year Evaluation of Primary Care Pharmacist Practices.
Pharmacy (Basel). 2019 Aug 3;7(3):105. doi: 10.3390/pharmacy7030105.
引用本文的文献
1
Anticholinergic medicines - medication management, prescribing cascades, and deprescribing.
Int J Clin Pharm. 2025 Aug 13. doi: 10.1007/s11096-025-01965-5.
2
Anticholinergic burden and health-related quality of life among adult patients in a resource-limited setting: a cross-sectional study.
Int J Clin Pharm. 2024 Dec;46(6):1352-1361. doi: 10.1007/s11096-024-01769-z. Epub 2024 Jul 15.
3
Increased anticholinergic medication use in middle-aged and older autistic adults and its associations with self-reported memory difficulties and cognitive decline.
Autism Res. 2024 Apr;17(4):852-867. doi: 10.1002/aur.3076. Epub 2023 Dec 18.
本文引用的文献
1
Global pandemic-the true incidence of adverse drug reactions.
Age Ageing. 2020 Oct 23;49(6):934-935. doi: 10.1093/ageing/afaa165.
2
Anticholinergic Burden Measures Predict Older People's Physical Function and Quality of Life: A Systematic Review.
J Am Med Dir Assoc. 2021 Jan;22(1):56-64. doi: 10.1016/j.jamda.2020.05.065. Epub 2020 Jul 21.
3
Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties.
Ann Fam Med. 2020 Mar;18(2):148-155. doi: 10.1370/afm.2501.
4
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis.
Br J Clin Pharmacol. 2015 Aug;80(2):209-20. doi: 10.1111/bcp.12617. Epub 2015 May 20.
5
Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic review.
Age Ageing. 2014 Sep;43(5):604-15. doi: 10.1093/ageing/afu096. Epub 2014 Jul 19.
6
Association between prescribing of antimuscarinic drugs and antimuscarinic adverse effects in older people.
Expert Rev Clin Pharmacol. 2010 Jul;3(4):441-52. doi: 10.1586/ecp.10.34.
7
Associations between the anticholinergic risk scale score and physical function: potential implications for adverse outcomes in older hospitalized patients.
J Am Med Dir Assoc. 2011 Oct;12(8):565-572. doi: 10.1016/j.jamda.2011.03.006. Epub 2011 Apr 21.
Zotero 插件